Ph+ ALL in Chinese Children: Diagnosis, Treatment, and Survival | MicrobiomeTrials← Back to trialsNCT07813208
Ph+ ALL in Chinese Children: Diagnosis, Treatment, and Survival
RecruitingOBSERVATIONAL
Trial Details
Start: 2025-08-01Est. Completion: 2026-09
Enrollment target: 500 participants Locations- The Children's Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Other microbiome trials you might be interested in
B Acute Lymphoblastic Leukemia
This pilot trial assesses the effect of the combination of blinatumomab with dasatinib or imatinib and standard chemothe…
Birmingham, United StatesEst. completion Dec 1, 2030
Very Rare TumorsVery Rare CancersOther Solid TumorsSolid TumorPediatric Rare Tumors
Background:
All childhood cancers are rare, but some are called very rare. Very rare cancers are diagnosed in 2 or fewe…
Bethesda, United States
Est. completion Apr 1, 2035